Stock Price Quote

VIJAYA DIAGNOSTIC CENTRE LTD.

NSE : VIJAYABSE : 543350ISIN CODE : INE043W01024Industry : Hospital & Healthcare ServicesHouse : Private
BSE692.501.35 (+0.2 %)
PREV CLOSE ( ) 691.15
OPEN PRICE ( ) 693.40
BID PRICE (QTY) 692.50 (2)
OFFER PRICE (QTY) 693.75 (1)
VOLUME 3373
TODAY'S LOW / HIGH ( )689.55 695.80
52 WK LOW / HIGH ( )349.5 718.9
NSE693.452.05 (+0.3 %)
PREV CLOSE( ) 691.40
OPEN PRICE ( ) 695.90
BID PRICE (QTY) 693.50 (1)
OFFER PRICE (QTY) 694.30 (17)
VOLUME 57044
TODAY'S LOW / HIGH( ) 688.95 697.10
52 WK LOW / HIGH ( )349.25 718.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 05-06 2002
Management Info
Sura Surendranath Reddy - Chairman - Managing Director
Registered Office

Address 6-3-883/ F , F P A Building,Near Topaz Building,Punjagutta,
Hyderabad,
Telangana-500082

Phone 040 2342 0411-12

Email info@vijayadiagnostic.com

Website www.vijayadiagnostic.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

06Apr Vijaya Diagnostic Centre informs abou
Vijaya Diagnostic Centre has informed that it enclosed a copy of the Com..
17Feb Vijaya Diagnostic Centre informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
30Jan Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that it enclosed the disclosure un..
22Dec Lupin, Infosys and Vijaya Diagnostic C
Lupin’s consumer healthcare business -- LupinLife has launched Softovac..
22Dec Vijaya Diagnostic Centre rises on comp
Vijaya Diagnostic Centre is currently trading at Rs. 653.70, up by 6.60..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit252.46832.35
Gross Profit 338.37 1112.74
Operating Profit 563.391935.44
Net Sales 1291.184495.79

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE)
peergroup  3550.00 (2.14%)
M.Cap ( in Cr)1645.94
Dr. Lal Pathlabs (BSE)
peergroup  2373.95 (1.89%)
M.Cap ( in Cr)19957.47
RainbowChildrenS Med (BSE)
peergroup  1349.00 (2.52%)
M.Cap ( in Cr)13645.38
Global Health (BSE)
peergroup  1457.05 (1.38%)
M.Cap ( in Cr)37859.54
Metropolis Health. (BSE)
peergroup  1807.90 (0.89%)
M.Cap ( in Cr)9308.79

Shareholding Pattern

PROMOTERS 54.06%
NON-INSTITUTION 5.05%
MUTUAL FUNDS/UTI 20.37%
FI/BANKS/INSURANCE 0.21%
GOVERNMENT 0%
FII 0%

About Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. was incorporated in the year 2002. Its today's share price is 692.5. Its current market capitalisation stands at Rs 7086.42 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4495.79 Cr and Total Income of Rs.4641.53 Cr. The company's management includes S Geeta Reddy, Manjula Anagani, Duvvuru Nageshwar Reddy, Shekhar Prasad Singh, Chavali Satyanaraynna Murthy, Sunil Chandra Kondapally, Sura Surendranath Reddy, Hansraj Singh Rajput.

It is listed on the BSE with a BSE Code of 543350 , NSE with an NSE Symbol of VIJAYA and ISIN of INE043W01024. It's Registered office is at 6-3-883/ F , F P A Building,Near Topaz Building,PunjaguttaHyderabad-500082, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.